National Health Investors (NHI)
National Health Investors on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as real estate investment trusts.
2.2M
Short interest
settlement 2026-10-15
6.6
Days to cover
+1.2 days vs prior
69.4%
Short share of volume
2026-11-02
340
Fails to deliver
settlement 2026-10-09
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in NHI is 2,229,964 shares, up 223,470 shares over the last month. Over the last 48 readings it ranged from 1,242,209 shares (27 February 2026) to 3,740,952 shares (30 June 2026). At the reported average volume of 338K shares a day that is 6.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/nhi" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,229,964 | -6.8% | 338,456 | 6.59 |
| 2026-09-30 | 2,391,392 | +19.2% | 444,983 | 5.37 |
| 2026-09-15 | 2,006,494 | -11.0% | 336,896 | 5.96 |
| 2026-08-31 | 2,255,467 | +3.8% | 285,204 | 7.91 |
| 2026-08-14 | 2,172,704 | +45.3% | 385,535 | 5.64 |
| 2026-07-31 | 1,495,586 | -28.6% | 403,656 | 3.71 |
| 2026-07-15 | 2,094,689 | -44.0% | 441,598 | 4.74 |
| 2026-06-30 | 3,740,952 | +102.4% | 1,574,464 | 2.38 |
| 2026-06-15 | 1,847,936 | -13.2% | 404,977 | 4.56 |
| 2026-05-29 | 2,127,626 | +12.9% | 445,919 | 4.77 |
| 2026-05-15 | 1,884,963 | +9.3% | 545,025 | 3.46 |
| 2026-04-30 | 1,725,412 | +3.8% | 389,036 | 4.44 |
| 2026-04-15 | 1,662,811 | -2.0% | 227,129 | 7.32 |
| 2026-03-31 | 1,697,062 | +14.7% | 387,508 | 4.38 |
| 2026-03-13 | 1,479,704 | +19.1% | 314,800 | 4.70 |
| 2026-02-27 | 1,242,209 | -8.3% | 353,558 | 3.51 |
| 2026-02-13 | 1,354,543 | +1.6% | 294,255 | 4.60 |
| 2026-01-30 | 1,333,460 | +0.7% | 219,212 | 6.08 |
| 2026-01-15 | 1,323,622 | -4.6% | 180,219 | 7.34 |
| 2025-12-31 | 1,387,280 | -29.8% | 230,633 | 6.02 |
| 2025-12-15 | 1,975,807 | +5.9% | 222,505 | 8.88 |
| 2025-11-28 | 1,865,181 | +1.8% | 167,287 | 11.15 |
| 2025-11-14 | 1,832,706 | +0.5% | 220,100 | 8.33 |
| 2025-10-31 | 1,822,866 | +3.2% | 171,413 | 10.63 |
| 2025-10-15 | 1,765,722 | -1.5% | 222,531 | 7.93 |
| 2025-09-30 | 1,793,148 | -3.5% | 233,011 | 7.70 |
| 2025-09-15 | 1,858,767 | +1.9% | 197,888 | 9.39 |
| 2025-08-29 | 1,823,169 | -3.0% | 188,247 | 9.68 |
| 2025-08-15 | 1,879,892 | +0.7% | 253,392 | 7.42 |
| 2025-07-31 | 1,867,474 | -5.5% | 214,447 | 8.71 |
| 2025-07-15 | 1,975,146 | -5.3% | 267,354 | 7.39 |
| 2025-06-30 | 2,086,338 | -21.0% | 368,064 | 5.67 |
| 2025-06-13 | 2,641,720 | +31.1% | 327,982 | 8.05 |
| 2025-05-30 | 2,014,284 | +34.5% | 286,407 | 7.03 |
| 2025-05-15 | 1,497,262 | +2.6% | 235,650 | 6.35 |
| 2025-04-30 | 1,458,856 | -4.2% | 213,354 | 6.84 |
| 2025-04-15 | 1,523,292 | -7.1% | 252,631 | 6.03 |
| 2025-03-31 | 1,640,482 | -22.2% | 257,003 | 6.38 |
| 2025-03-14 | 2,107,697 | +1.9% | 258,995 | 8.14 |
| 2025-02-28 | 2,068,069 | +2.6% | 260,042 | 7.95 |
| 2025-02-14 | 2,016,210 | +0.6% | 175,082 | 11.52 |
| 2025-01-31 | 2,004,028 | -5.5% | 163,890 | 12.23 |
| 2025-01-15 | 2,121,104 | +3.7% | 225,820 | 9.39 |
| 2024-12-31 | 2,045,078 | -6.8% | 307,822 | 6.64 |
| 2024-12-13 | 2,193,309 | -1.4% | 222,376 | 9.86 |
| 2024-11-29 | 2,224,648 | +53.3% | 217,317 | 10.24 |
| 2024-11-15 | 1,451,594 | +7.8% | 357,666 | 4.06 |
| 2024-10-31 | 1,347,007 | -48.3% | 204,766 | 6.58 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of NHI volume is 69.4%, up 1.6 points over the last five sessions. Over the last 30 readings it ranged from 35.7% (15 October 2026) to 74.2% (1 October 2026). The latest reading is 9.8 points above the 30-session average of 59.6%, on 91K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 63K | 91K | 69.4% | 0 |
| 2026-10-30 | 54K | 90K | 59.6% | 0 |
| 2026-10-29 | 27K | 49K | 54.6% | 0 |
| 2026-10-28 | 51K | 82K | 62.4% | 0 |
| 2026-10-27 | 57K | 85K | 67.1% | 0 |
| 2026-10-26 | 59K | 87K | 67.8% | 5 |
| 2026-10-23 | 77K | 113K | 68.0% | 7 |
| 2026-10-22 | 40K | 66K | 60.9% | 0 |
| 2026-10-21 | 44K | 74K | 59.5% | 0 |
| 2026-10-20 | 58K | 97K | 60.4% | 0 |
| 2026-10-19 | 55K | 80K | 68.9% | 0 |
| 2026-10-16 | 53K | 75K | 70.9% | 0 |
| 2026-10-15 | 21K | 60K | 35.7% | 0 |
| 2026-10-14 | 23K | 50K | 46.1% | 0 |
| 2026-10-13 | 38K | 69K | 54.5% | 0 |
| 2026-10-12 | 66K | 98K | 67.4% | 0 |
| 2026-10-09 | 22K | 50K | 45.1% | 0 |
| 2026-10-08 | 77K | 128K | 60.4% | 0 |
| 2026-10-07 | 46K | 87K | 53.3% | 0 |
| 2026-10-06 | 93K | 144K | 64.4% | 3 |
| 2026-10-05 | 104K | 215K | 48.3% | 2 |
| 2026-10-02 | 94K | 152K | 61.6% | 1 |
| 2026-10-01 | 131K | 177K | 74.2% | 0 |
| 2026-09-30 | 65K | 113K | 57.1% | 0 |
| 2026-09-29 | 132K | 191K | 69.2% | 0 |
| 2026-09-28 | 55K | 94K | 58.7% | 0 |
| 2026-09-25 | 47K | 90K | 51.9% | 0 |
| 2026-09-24 | 79K | 128K | 61.3% | 0 |
| 2026-09-23 | 60K | 107K | 56.0% | 0 |
| 2026-09-22 | 47K | 87K | 53.4% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in NHI is 340 shares, down 5,891 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (13 July 2026) to 704,419 shares (30 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 340 | $64.58 | $22K |
| 2026-10-06 | 6,231 | $65.02 | $405K |
| 2026-10-05 | 4 | $65.72 | $263 |
| 2026-09-30 | 6,868 | $66.66 | $458K |
| 2026-09-28 | 16 | $66.92 | $1K |
| 2026-09-14 | 1,906 | $70.32 | $134K |
| 2026-09-11 | 20 | $70.21 | $1K |
| 2026-09-10 | 55 | $70.19 | $4K |
| 2026-09-09 | 520 | $71.42 | $37K |
| 2026-08-26 | 349 | $73.35 | $26K |
| 2026-08-20 | 672 | $74.08 | $50K |
| 2026-08-18 | 1,528 | $73.41 | $112K |
| 2026-08-17 | 47 | $72.95 | $3K |
| 2026-08-07 | 100 | $75.38 | $8K |
| 2026-08-05 | 12 | $74.56 | $895 |
| 2026-07-23 | 5 | $79.98 | $400 |
| 2026-07-15 | 164 | $76.12 | $12K |
| 2026-07-13 | 4 | $75.33 | $301 |
| 2026-07-08 | 1,899 | $77.31 | $147K |
| 2026-07-02 | 908 | $76.55 | $70K |
| 2026-07-01 | 908 | $76.26 | $69K |
| 2026-06-30 | 704,419 | $77.60 | $54.7M |
| 2026-06-29 | 4,497 | $77.55 | $349K |
| 2026-06-22 | 1,000 | $70.82 | $71K |
| 2026-06-15 | 353 | $72.10 | $25K |
| 2026-05-21 | 331 | $77.48 | $26K |
| 2026-03-17 | 606 | $86.24 | $52K |
| 2026-02-17 | 31 | $89.31 | $3K |
| 2026-02-02 | 732 | $82.12 | $60K |
| 2026-01-28 | 79 | $79.23 | $6K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for NHI in the last 90 days. The most recent filings are listed below. Latest filing: Maingot Christian Ken (Chief Operating Officer) on 2026-07-27.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-27 | Maingot Christian Ken | Chief Operating Officer | Grant | 2K | $0.00 | $0 | 2K |
| 2026-06-15 | MCCABE ROBERT A JR | Director | Buy | 890 | $71.65 | $64K | 44K |
| 2026-06-05 | Mendelsohn D. Eric | CEO and President | Buy | 2K | $68.84 | $103K | 133K |
| 2026-06-05 | Jobe James R | Director | Gift | 225 | $0.00 | $0 | 33K |
| 2026-05-05 | Spaid John L | CFO/EVP Finance | Tax withholding | 314 | $73.09 | $23K | 56K |
| 2026-05-05 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 282 | $73.09 | $21K | 41K |
| 2026-05-05 | Mendelsohn D. Eric | CEO and President | Tax withholding | 394 | $73.09 | $29K | 132K |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Grant | 5K | $0.00 | $0 | 57K |
| 2026-03-03 | PASCOE KEVIN CARLTON | Chief Investment Officer | Grant | 5K | $0.00 | $0 | 73K |
| 2026-03-03 | Todd Candice W | Director | Grant | 1K | $0.00 | $0 | 3K |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Tax withholding | 14K | $86.75 | $1.2M | 56K |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Exercise or conversion | 15K | $73.34 | $1.1M | 70K |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Tax withholding | 511 | $86.75 | $44K | 55K |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Grant | 5K | $0.00 | $0 | 55K |
| 2026-03-03 | PASCOE KEVIN CARLTON | Chief Investment Officer | Grant | 5K | $0.00 | $0 | 73K |
| 2026-03-03 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 411 | $86.75 | $36K | 41K |
| 2026-03-03 | Travis David L | SVP/Chief Accounting Officer | Grant | 3K | $0.00 | $0 | 41K |
| 2026-03-03 | Mendelsohn D. Eric | CEO and President | Tax withholding | 597 | $86.75 | $52K | 132K |
| 2026-03-03 | Mendelsohn D. Eric | CEO and President | Grant | 14K | $0.00 | $0 | 133K |
| 2026-03-03 | MCCABE ROBERT A JR | Director | Grant | 1K | $0.00 | $0 | 43K |
| 2026-03-03 | Jobe James R | Director | Grant | 1K | $0.00 | $0 | 1K |
| 2026-03-03 | Donohue Lilly | Director | Grant | 1K | $0.00 | $0 | 1K |
| 2026-03-03 | Chapin Robert | Director | Grant | 1K | $0.00 | $0 | 1K |
| 2026-03-03 | COLDEN TRACY M J | Director | Grant | 1K | $0.00 | $0 | 13K |
| 2026-03-03 | Blankenship Elizabeth Jackson | SVP, Legal Affairs | Grant | 2K | $0.00 | $0 | 2K |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $57.76 | $481K | 49K |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 19K | $90.03 | $1.7M | 38K |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $57.76 | $481K | 57K |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $57.76 | $481K | 40K |
| 2026-02-23 | PASCOE KEVIN CARLTON | Chief Investment Officer | Tax withholding | 6K | $90.03 | $577K | 68K |
| 2026-02-23 | PASCOE KEVIN CARLTON | Chief Investment Officer | Exercise or conversion | 9K | $57.76 | $491K | 75K |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Tax withholding | 236 | $90.03 | $21K | 51K |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Tax withholding | 6K | $90.03 | $568K | 51K |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Exercise or conversion | 9K | $57.76 | $491K | 57K |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Tax withholding | 194 | $90.03 | $17K | 118K |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Tax withholding | 10K | $90.03 | $918K | 119K |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 13K | $57.76 | $770K | 129K |
| 2026-02-19 | COLDEN TRACY M J | Director | Tax withholding | 8K | $88.72 | $733K | 12K |
| 2026-02-19 | COLDEN TRACY M J | Director | Exercise or conversion | 10K | $73.34 | $733K | 20K |
| 2026-02-17 | Mendelsohn D. Eric | CEO and President | Tax withholding | 22K | $91.02 | $2.0M | 115K |
| 2026-02-17 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 25K | $73.34 | $1.8M | 138K |
| 2026-02-17 | Jobe James R | Director | Tax withholding | 8K | $91.02 | $733K | 33K |
| 2026-02-17 | Jobe James R | Director | Exercise or conversion | 10K | $73.34 | $733K | 42K |
| 2026-02-12 | MCCABE ROBERT A JR | Director | Tax withholding | 8K | $89.66 | $733K | 42K |
| 2026-02-12 | MCCABE ROBERT A JR | Director | Exercise or conversion | 10K | $73.34 | $733K | 50K |
| 2026-02-11 | PASCOE KEVIN CARLTON | Chief Investment Officer | Tax withholding | 13K | $88.25 | $1.2M | 66K |
| 2026-02-11 | PASCOE KEVIN CARLTON | Chief Investment Officer | Exercise or conversion | 15K | $73.34 | $1.1M | 80K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $54.73 | $456K | 53K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 29K | $85.10 | $2.5M | 32K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $54.73 | $456K | 61K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 8K | $54.73 | $456K | 44K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 10K | $53.41 | $523K | 36K |
| 2026-02-09 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 2K | $53.41 | $128K | 26K |
| 2026-02-05 | Todd Candice W | Director | Tax withholding | 9K | $84.26 | $733K | 1K |
| 2026-02-05 | Todd Candice W | Director | Exercise or conversion | 10K | $73.34 | $733K | 10K |
| 2026-02-01 | Gaines Kristin Sallee | SVP/Chief Transaction Officer | Exercise or conversion | 18K | $53.41 | $979K | 99K |
| 2026-02-01 | Gaines Kristin Sallee | SVP/Chief Transaction Officer | Exercise or conversion | 43K | $82.12 | $3.5M | 74K |
| 2026-02-01 | Gaines Kristin Sallee | SVP/Chief Transaction Officer | Exercise or conversion | 18K | $53.41 | $979K | 117K |
| 2026-02-01 | Gaines Kristin Sallee | SVP/Chief Transaction Officer | Exercise or conversion | 18K | $53.41 | $979K | 80K |
| 2026-01-30 | PASCOE KEVIN CARLTON | Chief Investment Officer | Exercise or conversion | 9K | $57.76 | $491K | 78K |
| 2026-01-30 | PASCOE KEVIN CARLTON | Chief Investment Officer | Tax withholding | 14K | $82.12 | $1.1M | 65K |
| 2026-01-30 | PASCOE KEVIN CARLTON | Chief Investment Officer | Exercise or conversion | 9K | $54.73 | $465K | 70K |
| 2026-01-27 | ADAMS ROBERT G | Director | Tax withholding | 31K | $79.23 | $2.5M | 184K |
| 2026-01-27 | ADAMS ROBERT G | Director | Exercise or conversion | 10K | $73.34 | $733K | 216K |
| 2026-01-27 | ADAMS ROBERT G | Director | Exercise or conversion | 25K | $69.20 | $1.7M | 206K |
| 2026-01-16 | Spaid John L | CFO/EVP Finance | Exercise or conversion | 9K | $57.76 | $491K | 61K |
| 2026-01-16 | Spaid John L | CFO/EVP Finance | Tax withholding | 28K | $80.43 | $2.2M | 49K |
| 2026-01-16 | Spaid John L | CFO/EVP Finance | Exercise or conversion | 15K | $73.34 | $1.1M | 76K |
| 2026-01-16 | Spaid John L | CFO/EVP Finance | Exercise or conversion | 9K | $54.73 | $465K | 53K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 42K | $69.20 | $2.9M | 179K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Tax withholding | 135K | $79.23 | $10.7M | 113K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 13K | $57.76 | $770K | 248K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 13K | $54.73 | $730K | 234K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 42K | $69.20 | $2.9M | 221K |
| 2026-01-15 | Mendelsohn D. Eric | CEO and President | Exercise or conversion | 42K | $69.20 | $2.9M | 138K |
| 2026-01-14 | MCCABE ROBERT A JR | Director | Tax withholding | 22K | $79.23 | $1.7M | 38K |
| 2026-01-14 | MCCABE ROBERT A JR | Director | Exercise or conversion | 25K | $69.20 | $1.7M | 60K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Exercise or conversion | 10K | $73.34 | $733K | 190K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Exercise or conversion | 10K | $57.76 | $578K | 180K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Exercise or conversion | 25K | $53.41 | $1.3M | 160K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Tax withholding | 63K | $78.37 | $4.9M | 127K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Exercise or conversion | 10K | $54.73 | $547K | 170K |
| 2025-12-09 | SWAFFORD CHARLOTTE A | Director | Exercise or conversion | 25K | $69.20 | $1.7M | 135K |
| 2025-11-20 | Jobe James R | Director | Tax withholding | 22K | $78.16 | $1.7M | 32K |
| 2025-11-20 | Jobe James R | Director | Exercise or conversion | 25K | $69.20 | $1.7M | 54K |
| 2025-09-23 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 21K | $80.06 | $1.7M | 24K |
| 2025-09-23 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 11K | $69.20 | $784K | 45K |
| 2025-09-23 | Travis David L | SVP/Chief Accounting Officer | Exercise or conversion | 12K | $69.20 | $807K | 33K |
| 2025-05-05 | Mendelsohn D. Eric | CEO and President | Tax withholding | 394 | $76.04 | $30K | 96K |
| 2025-05-05 | Spaid John L | CFO/EVP Finance | Tax withholding | 259 | $76.04 | $20K | 44K |
| 2025-03-28 | ADAMS ROBERT G | Director | Exercise or conversion | 10K | $57.76 | $578K | 375K |
| 2025-03-28 | ADAMS ROBERT G | Director | Exercise or conversion | 10K | $54.73 | $547K | 365K |
| 2025-03-28 | ADAMS ROBERT G | Director | Exercise or conversion | 25K | $53.41 | $1.3M | 355K |
| 2025-03-28 | ADAMS ROBERT G | Director | Tax withholding | 33K | $74.70 | $2.5M | 342K |
| 2025-03-03 | Spaid John L | CFO/EVP Finance | Grant | 7K | $0.00 | $0 | 45K |
| 2025-03-03 | Travis David L | SVP/Chief Accounting Officer | Grant | 6K | $0.00 | $0 | 22K |
| 2025-03-03 | Gaines Kristin Sallee | SVP/Chief Transaction Officer | Grant | 4K | $0.00 | $0 | 62K |
| 2025-03-03 | PASCOE KEVIN CARLTON | Chief Investment Officer | Grant | 6K | $0.00 | $0 | 61K |
| 2025-03-03 | Mendelsohn D. Eric | CEO and President | Grant | 8K | $0.00 | $0 | 97K |
| 2025-02-23 | Spaid John L | CFO/EVP Finance | Tax withholding | 267 | $68.96 | $18K | 38K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for NHI worth $2.4M at the prices reported; 1 in the last 90 days worth $2.4M. Latest: Spaid John L filed on 2026-08-17 to sell 33,124 shares ($2.4M) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-17 | Spaid John LOfficer | 33K | $2.4M | 0.067% | 2026-08-17 | Charles Schwab Corp. |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of NHI in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 17.6% of the class (8,523,688 shares), filed 2026-07-08 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G/Ano. 1 | Vanguard Portfolio Managementinvestment adviser | 4.8M | 9.8% | 2026-09-30 |
| 2026-08-07 | 13G | STATE STREET CORPORATIONparent holding company | 2.7M | 5.6% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 2 | BlackRock, Inc.parent holding company | 8.5M | 17.6% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 2.5M | 5.1% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 19 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding NHI at their latest 13F. JSON5 of the 30 tracked managers held NHI at their latest 13F, $52.6M in total at quarter-end prices. Two Sigma Investments is the largest at $25.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 335K | $25.6M | 0.02% | -85K |
| Citadel Advisors | 2026-06-30 | 179K | $13.6M | 0.00% | +46K |
| Millennium Management | 2026-06-30 | 79K | $6.0M | 0.00% | -683K |
| Renaissance Technologies | 2026-06-30 | 52K | $4.0M | 0.01% | +10K |
| AQR Capital Management | 2026-06-30 | 44K | $3.4M | 0.00% | -4K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) National Health Investors reported revenue of $44.8M, up 215.0% from the same quarter a year earlier, and net income of $55.7M (1.15 diluted EPS). In FY 2025 it generated $236.6M of operating cash flow and spent $169.7M on dividends.
- Cash
- $30.4M
- Equity
- $1.57B
- Total assets
- $2.96B
- Shares outstanding
- 49,110,434
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $44.8M | $55.7M | 124.3% | 1.15 |
| Q1 FY 2026 | 2026-03-31 | $37.1M | $40.1M | 108.2% | 0.82 |
| Q4 FY 2025derived | 2025-12-31 | $30.7M | $38.2M | 124.2% | n/a |
| Q3 FY 2025 | 2025-09-30 | $21.2M | $32.9M | 155.2% | 0.69 |
| Q2 FY 2025 | 2025-06-30 | $14.2M | $37.0M | 260.2% | 0.79 |
| Q1 FY 2025 | 2025-03-31 | $13.9M | $34.2M | 245.1% | 0.74 |
| Q4 FY 2024derived | 2024-12-31 | $14.0M | $43.2M | 308.8% | n/a |
| Q3 FY 2024 | 2024-09-30 | $13.8M | $28.5M | 207.2% | 0.65 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $80.1M | $142.2M | $236.6M | $294.0M | n/a | $169.7M |
| FY 2024 | 2024-12-31 | $54.4M | $138.0M | $207.8M | $157.9M | $0 | $156.5M |
| FY 2023 | 2023-12-31 | $48.8M | $135.7M | $184.4M | $49.6M | $0 | $156.2M |
| FY 2022 | 2022-12-31 | $35.8M | $66.4M | $185.3M | $11.0M | $152.0M | $161.8M |
| FY 2021 | 2021-12-31 | $0 | $111.8M | $210.9M | $50.3M | $0 | $182.9M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
National Health Investors in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows National Health Investors (NHI), SEC CIK 877860, listed on NYSE, classified by the SEC as real estate investment trusts. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-27.JSON and CSV
- Company record
- EDGAR filing index for CIK 877860Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as real estate investment trusts
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of NHI is sold short?
2,229,964 shares were held short at the 2026-10-15 settlement, 6.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NHI's daily short volume?
On 2026-11-02, 63,466 of the 91,489 NHI shares reported to FINRA were sold short, 69.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NHI have fails to deliver?
The SEC's latest file shows 340 NHI shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are NHI insiders buying or selling?
No open-market insider trades were reported for NHI in the last 90 days. The most recent filings are listed below. Latest filing: Maingot Christian Ken (Chief Operating Officer) on 2026-07-27.
Have NHI insiders filed to sell?
1 Form 144 notice on file for NHI worth $2.4M at the prices reported; 1 in the last 90 days worth $2.4M. Latest: Spaid John L filed on 2026-08-17 to sell 33,124 shares ($2.4M) from 2026-08-17.
Who owns 5% or more of NHI?
4 holders report 5% or more of NHI in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 17.6% of the class (8,523,688 shares), filed 2026-07-08 for an event on 2026-06-30.
What did NHI report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) National Health Investors reported revenue of $44.8M, up 215.0% from the same quarter a year earlier, and net income of $55.7M (1.15 diluted EPS). In FY 2025 it generated $236.6M of operating cash flow and spent $169.7M on dividends.
Which tracked 13F managers own NHI?
5 of the 30 tracked 13F managers held NHI shares at their latest filing, $52.6M in all. The largest: Two Sigma Investments (335K shares, $25.6M), Ken Griffin's Citadel Advisors (179K shares, $13.6M), Izzy Englander's Millennium Management (79K shares, $6.0M), Renaissance Technologies (52K shares, $4.0M), Cliff Asness's AQR Capital Management (44K shares, $3.4M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.